Search results
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Investor's Business Daily· 2 years agoMerck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris...
Understanding Your Treatment Options for Type 2 Diabetes
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Jason DelCollo, DO There are standard treatments for type 2 diabetes, but each...
Medicare recipients say new drug price negotiations will save them thousands
ABC News via Yahoo News· 8 months agoEvery month, Dawn LaGuerre has to decide which bills she's going to pay or if she needs to cut back...
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Zacks via Yahoo Finance· 2 years agoMerck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to...
Medications for Type 2 Diabetes
Verywell Health via Yahoo News· 8 months agoType 2 diabetes can be managed with lifestyle modifications alone (changes in diet and regular exercise), but typically, type 2 diabetes is treated with...
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Motley Fool· 8 months agoAbout a year ago, President Joe Biden signed the Inflation Reduction Act into law. Among the many...
To Avoid Supply Crunch, FDA Temporarily Allows Higher Impurity Levels In Merck's Diabetes Drug:...
Benzinga via Yahoo Finance· 2 years agoThe FDA recently became aware of a nitrosamine impurity, Nitroso-STG-19 or NTTP, in certain samples...
Combination Therapy for Type 2 Diabetes
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Do-Eun Lee, MD Most people with type 2 diabetes eventually need multiple medications to help them manage their blood sugar...
Medicare can now negotiate prices on these drugs to help seniors save
Newsy via AOL· 8 months agoThe exterior of Pfizer in Groton, Conn. The Biden administration announced the first 10 drugs...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 8 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...